Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds targeting central nervous system disorders and metabolic diseases. Its rigid cyclobutane scaffold with a trifluoromethyl group enhances metabolic stability and binding selectivity in drug molecules. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its stereochemical configuration and polarity. Also utilized in the preparation of protease inhibitors and receptor modulators where fluorinated amines improve pharmacokinetic properties.